In 2026, Singapore approved cultivated duck and beef, marking the first time regulators cleared products beyond poultry and seafood. While Singapore leads in the number of authorizations, other countries including the United States, Israel, and Australia have also established regulatory frameworks. Despite these approvals, no cultivated meat product is currently sold at a commercial scale. Companies are shifting their business models toward shared manufacturing infrastructure to manage costs. Recent production trials suggest potential price reductions through increased volume and improved cell culture efficiency, though analysts note that achieving mainstream affordability depends on sustained research and the replacement of expensive production inputs. The sector is currently transitioning from initial regulatory milestones to the challenge of establishing viable, large-scale commercial production.
From cells to real meat
